Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate

Various types of vaccines, such as mRNA, adenovirus, and inactivated virus by injection, have been developed to prevent SARS-CoV-2 infection. Although some of them have already been approved under the COVID-19 pandemic, various drawbacks, including severe side effects and the requirement for sub-zer...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Johnny Chun-Chau, Liu, Ying, Wu, Kam-Chau, Choi, Man-Chung, Ma, Chloe Ho-Yi, Lin, Jayman, He, Emily Isabel Cheng, Leung, David Yiu-Ming, Sze, Eric Tung-Po, Hamied, Yusuf Khwaja, Lam, Dominic Man-Kit, Kwong, Keith Wai-Yeung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780001/
https://www.ncbi.nlm.nih.gov/pubmed/35062663
http://dx.doi.org/10.3390/vaccines10010002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780001/
https://www.ncbi.nlm.nih.gov/pubmed/35062663
http://dx.doi.org/10.3390/vaccines10010002

Ejemplares similares